Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Normal plasma cells,Low proliferation multiple myeloma and High proliferation multiple myeloma cells

ABSTRACT: CD138 sorted bone marrow plasma cell were obtained from a normal patient, a multiple myelow with slow proliferation and a multiple myelow with rapid proliferation.

ORGANISM(S): Human Homo Sapiens

TISSUE(S): Bone Marrow

DISEASE(S): Cancer

SUBMITTER: William Gonsalves

PROVIDER: ST000221 | MetabolomicsWorkbench | Sat Jun 20 00:00:00 BST 2015

REPOSITORIES: MetabolomicsWorkbench

ACCESS DATA

Json Xml

Similar Datasets

SFXN2 adjusts cell proliferation in multiple myeloma

Project description:SFXN2 adjusts cell proliferation in multiple myeloma

2021-07-28 | PXD027607 | iProX

Multiple Myeloma cells

Project description:Multiple Myeloma cells

| PRJNA800411 | ENA

Multiple myeloma

Project description:Multiple myeloma

| PRJNA515992 | ENA

miRNA profiling of multiple myeloma, MGUS, multiple myeloma cell lines and normal plasma cells

Project description:miRNA profiling in multiple myeloma - microRNAs represent a class of noncoding regulators of gene expression implicated in several biological and pathophysiological processes, including cancer. We investigate here their role in multiple myeloma using miChip-arrays interrogating 559 miRNAs in 92 purified myeloma-, MGUS-, normal plasma cell- and myeloma cell line samples. Impact on gene expression is assessed by Affymetrix U133 2.0 DNA-microarrays in 741 samples including two cohorts of 332 and 345 myeloma patients; chromosomal aberrations are assessed by iFISH, survival for 247 and 345 patients undergoing up-front high-dose therapy and autologous stem cell transplantation. Compared to normal plasma cells, 67/559 (12%) miRNAs are differentially expressed with fold changes of 4.6 to -3.1 in myeloma-, 20 (3.6%) in MGUS-samples, and three (0.5%) between MGUS- and myeloma-samples. Expression of miRNAs is associated with biological and pathophysiological parameters, i.e. proliferation, chromosomal aberrations, e.g. t(4;14), tumor mass, and gene expression-based high-risk scores. This holds true for target-gene signatures of regulated mRNAs. miRNA-expression confers prognostic significance for event-free (72/559) and overall survival (69/559), as do respective target-gene signatures. In conclusion, the miRNome of myeloma confers a pattern of small changes of individual miRNAs compared to normal plasma cells impacting on gene expression, biological functions, and survival.

2014-01-09 | E-MTAB-1363 | biostudies-arrayexpress

Proliferation-correlated expression

Project description:To determine how gene expression varies between fast and slow proliferating cells we developed a CFSE-based method to sort cells by intrapopulation heterogeneity in proliferation rate. We sorted cells by proliferation rate, as well as by the mitochondria dye TMRE, and performed mRNA-seq.

2019-10-31 | GSE139594 | GEO

Study on the effect and mechanism of GART in regulating the proliferation of multiple myeloma

Project description:Study on the effect and mechanism of GART in regulating the proliferation of multiple myeloma

2023-09-26 | PXD045718 | iProX

DOT1L inhibition blocks multiple myeloma cell proliferation through suppressing IRF4-MYC signaling

Project description:DOT1L inhibition blocks multiple myeloma cell proliferation through suppressing IRF4-MYC signaling

| PRJNA428234 | ENA

YB-1 inhibits proliferation of mesothelioma cells through multiple mechanisms

Project description:YB-1 inhibits proliferation of mesothelioma cells through multiple mechanisms

| PRJNA642157 | ENA

Che-1/AATF-induced transcriptionally active chromatin promotes cell proliferation in Multiple Myeloma

Project description:Che-1/AATF-induced transcriptionally active chromatin promotes cell proliferation in Multiple Myeloma